Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess efficacy and safety of patients who receive Adebrelimab combined with chemotherapy±chest radiotherapy as first-line treatment of extensive stage small cell lung ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hebei Medical University Fourth Hospital
NCT07113691 · Extensive Stage Small Cell Lung Cancer (ES-SCLC)
NCT07037758 · Extensive Stage Small Cell Lung Cancer
NCT05142696 · Extensive Stage Small Cell Lung Cancer
NCT05468489 · Extensive Stage Small Cell Lung Cancer
NCT07547332 · Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Jun Wang
Shijiazhuang, Hebei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions